Viewing data from:

ZILEUTON

ANDA

ZILEUTON | A204929 | RISING PHARMA HOLDINGS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$1.92

per ea

Lowest NADAC/Unit

$1.92

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980020612ZILEUTON ER 600 MG TABLET	$1.92	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

MATRIX PHARMACORP PRIVATE LTDZILEUTON USP

DMF 243342011

MSN LABORATORIES PRIVATE LTDZILEUTON USP [ROUTE CODE "ZN"]

DMF 248272011

EMCURE PHARMACEUTICALS LTDZILEUTON USP

DMF 258052012

BIOPHORE INDIA PHARMACEUTICALS PVT LTDZILEUTON

DMF 264462012

ERREGIERRE SPAZILEUTON USP

DMF 269952013

SOLARA ACTIVE PHARMA SCIENCES LTDZILEUTON USP

DMF 315782017

OPTIMUS DRUGS PRIVATE LTDZILEUTON

DMF 351372020

FARMAK ASInactiveZILEUTON

DMF 276792013

FARMAK ASInactiveZILEUTON USP

DMF 321102017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 600MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Mar 17, 2017

No patent or exclusivity listings for this strength.